Main Menu
NewsPDF

R. Matthew Neff Named to Bioanalytical Systems Board of Directors

08.18.2017

Bingham Greenebaum Doll LLP would like to congratulate attorney R. Matthew Neff on his recent election to serve on the Board of Directors for Bioanalytical System (BASi).

"We are pleased to welcome Mr. Neff to the Board and look forward to working with him. His strong management, financial and legal background will be important, as we continue to focus on driving value for our shareholders," said Greg Davis, interim chairman of the BASi board.

BASi is a provider of contract research services and sophisticated, niche instrumentation to the life sciences industry, primarily in drug research, discovery, and development in commercial and academic settings. BASi has established itself as an industry leader in contract research and a resource for pharmaceutical companies, academic centers, and startups around the globe.

Neff is an attorney in the firm’s Corporate Services Department. He focuses on advising clients on business, regulatory and finance matters, including mergers and acquisitions. Neff has served in numerous leadership positions, including Chairman, President and CEO, for multiple high profile companies. He has served on the Board of Governors of the Riley Children’s Foundation where he was chairman of the first-ever Capital Campaign of Riley, raising over $200 million for Indiana’s pediatric hospital. He also serves on the board of the Fairbanks Addiction Treatment Centers, among others.

Please join us in congratulating Matthew on his prestigious appointment to a life science industry leader!


You can read “Matt Neff '77 Elected to Bioanalytical Systems Board” on the DePauw University website.

Attorneys

Back to Page